These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 1985158
1. Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study. Smit EF, Willemse PH, Sleijfer DT, Uges DR, Postmus PE, Meijer S, Terheggen PM, Mulder NH, de Vries EG. J Clin Oncol; 1991 Jan; 9(1):100-10. PubMed ID: 1985158 [Abstract] [Full Text] [Related]
2. A phase I and pharmacokinetics study of prolonged ambulatory-infusion carboplatin. Olver IN, Webster LK, Millward MJ, Stokes KH, Bishop JF. Cancer Chemother Pharmacol; 1995 Jan; 37(1-2):79-85. PubMed ID: 7497601 [Abstract] [Full Text] [Related]
3. A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone. Greidanus J, de Vries EG, Mulder NH, Sleijfer DT, Uges DR, Oosterhuis B, Willemse PH. J Clin Oncol; 1989 Jun; 7(6):790-7. PubMed ID: 2715807 [Abstract] [Full Text] [Related]
4. A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin. de Vries EG, Greidanus J, Mulder NH, Nieweg MB, Postmus PE, Schipper DL, Sleijfer DT, Uges DR, Willemse PH. J Clin Oncol; 1987 Sep; 5(9):1445-51. PubMed ID: 3476690 [Abstract] [Full Text] [Related]
5. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion. Sasaki Y, Amano T, Morita M, Shinkai T, Eguchi K, Tamura T, Ohe Y, Kojima A, Saijo N. Cancer Res; 1991 Mar 01; 51(5):1472-7. PubMed ID: 1997185 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumors. Warren K, Gervais A, Aikin A, Egorin M, Balis FM. Cancer Chemother Pharmacol; 2004 Sep 01; 54(3):206-12. PubMed ID: 15156345 [Abstract] [Full Text] [Related]
7. Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study. Groen HJ, van der Leest AH, de Vries EG, Uges DR, Szabó BG, Mulder NH. Br J Cancer; 1995 Oct 01; 72(4):992-7. PubMed ID: 7547255 [Abstract] [Full Text] [Related]
8. Phase I clinical trial of the novel platin complex dicycloplatin: clinical and pharmacokinetic results. Li S, Huang H, Liao H, Zhan J, Guo Y, Zou BY, Jiang WQ, Guan ZZ, Yang XQ. Int J Clin Pharmacol Ther; 2013 Feb 01; 51(2):96-105. PubMed ID: 23127487 [Abstract] [Full Text] [Related]
9. Combined carboplatin and cisplatin. Limited prospects for dose intensification. Waterhouse DM, Reynolds RK, Natale RB. Cancer; 1993 Jun 15; 71(12):4060-6. PubMed ID: 8508371 [Abstract] [Full Text] [Related]
11. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer. Meerpohl HG, du Bois A, Kühnle H, Lück HJ, Kreienberg R, Möbus V, Bauknecht T, Köchli O, Bochtler H, Diergarten K. Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):7-12. PubMed ID: 8643973 [Abstract] [Full Text] [Related]
12. Infusional carboplatin. Phase I studies of 5-day and 14-day infusions. Lokich J, Anderson N, Bern M, Zipli T, Gonsalves L, Moore C. Cancer; 1991 Jul 01; 68(1):68-71. PubMed ID: 2049755 [Abstract] [Full Text] [Related]